FOLH1 and prostate carcinoma: The latter finding may hypothetically, in part, explain the non-response of PSMA-avid lesions to [177Lu]-PSMA-617, given the latter is rapidly released from endothelial cells following internalization, which is not the case for prostate cancer cells [53].